Search for: "Hyman Phelps McNamara" Results 161 - 180 of 215
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2011, 10:09 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. is pleased to announce that Diane B. [read post]
7 Mar 2011, 9:38 pm by Duncan
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
4 Mar 2011, 5:11 am by FDABlog HPM
  We also thank our Hyman, Phelps & McNamara, P.C. colleagues for their time and dedication to writing interesting and informative posts. [read post]
2 Feb 2011, 3:31 pm by FDABlog HPM
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
21 Jan 2011, 6:39 am by FDABlog HPM
  The program, titled “The Economics of Orphan Drugs – Why Successful Cures Bring Challenges for Patients and Payment,” will be posted on the internet here, and featues Peter Saltonstall, President & CEO of the National Organization for Rare Disorders, Frank Sasinowski, Chairman of the Board at NORD (and Hyman, Phelps & McNamara, P.C. [read post]
11 Jan 2011, 2:27 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C.'s Jeff Shapiro published an article in this month's MD&DI magazine -  What Happens to Medical Device Reports Once They Reach FDA? [read post]
29 Dec 2010, 5:30 pm by FDABlog HPM
In his latest article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
16 Dec 2010, 4:19 am by FDABlog HPM
Hyman Phelps & McNamara, P.C. is pleased to announce that Diane B. [read post]
12 Dec 2010, 9:11 am by FDABlog HPM
  At a December 8th retirement party, her contributions were recognized by almost all of the nine chief counsels with whom she worked (including Hyman, Phelps & McNamara’s Tom Scarlett), and she received the Distinguished Career Service Award from the FDA Commissioner and a Certificate of Appreciation from the HHS Secretary. [read post]
10 Dec 2010, 9:01 am by FDABlog HPM
  In August 2008, at the Democratic National Convention in Denver, Hyman, Phelps & McNamara’s Frank Sasinowski, the current chairman of the National Organization of Rare Diseases ("NORD"), had the idea to start a Congressional caucus on rare and neglected diseases in order to have a forum for issues that matter to the more than 25 million Americans with rare or orphan disorders. [read post]
6 Dec 2010, 11:14 pm by FDABlog HPM
Hyman, Phelps & McNamara’s Paul Hyman and Ricardo Carvajal recently published an article in Food Chemical News on the cost of inadequate substantiation of health-related claims made in the labeling and advertising of foods. [read post]
30 Nov 2010, 8:35 am by Eric Turkewitz
He’s a newcomer to the blogosphere and well worth the read; Drug & Device Law: BigLaw firm Dechert has a group blog that focuses on the defense of, well, drug and device cases; FDA Law Blog: Another newcomer to the blogosphere, the firm of Hyman, Phelps & McNamara focuses on government regulation of the food and drug biz; Jackson on Consumer Class Action and Mass Torts: Another BigLaw entry, this by Russell Jackson at Skadden, Arps, Slate, Meagher &… [read post]